欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号HR/H/0152/001
药品名称Carmustine Teva 100 mg powder and solvent for concentrate for solution for infusion
活性成分
    • carmustine 100.0 mg
剂型Powder and solvent for solution for infusion
上市许可持有人Teva B.V. Swensweg 5 2031GA Haarlem Netherlands
参考成员国 - 产品名称Croatia (HR)
Karmustin Teva 100 mg prašak i otapalo za koncentrat za otopinu za infuziju
互认成员国 - 产品名称
    • Netherlands (NL)
    • Spain (ES)
    • Portugal (PT)
    • Hungary (HU)
      Carmustine Teva 100 mg por és oldószer koncentrátum oldatos infúzióhoz
    • Bulgaria (BG)
      Carmustine Teva
    • Slovenia (SI)
      Karmustin Teva 100 mg prašek in vehikel za koncentrat za raztopino za infundiranje
许可日期2021/01/10
最近更新日期2022/09/02
药物ATC编码
    • L01AD01 carmustine
申请类型
  • TypeLevel1：Abridged
  • TypeLevel2：Initial Application
  • TypeLevel3：Generic Art 10.1 and 10.2 Dir 2001/83/EC
  • TypeLevel4：Chemical Substance
  • TypeLevel5：Prescription Only
附件文件下载
市场状态Positive
©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase